Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 1999 December;40(6) > The Journal of Cardiovascular Surgery 1999 December;40(6):781-5

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Share

 

ORIGINAL ARTICLES  CARDIAC PAPERS 

The Journal of Cardiovascular Surgery 1999 December;40(6):781-5

Copyright © 2000 EDIZIONI MINERVA MEDICA

lingua: Inglese

Hemodynamic effects of α-human atrial natriuretic polypeptide on patients undergoing open-heart surgery

Ohki S., Ishikawa S., Ohtaki A., Takahashi T., Kpyano T., Otani Y., Muramaki J., Mohara J., Isa Y.*, Kunimoto F.*, Morishita Y.

From the Second Department of Surgery *Intensive Care Unit Gunma University School of Medicine, Maebashi, Japan


PDF


Background. A car­diac hor­mone, α-­human atri­al nat­riu­ret­ic poly­pep­tide (α-hANP), ­acts as a vaso­di­la­tor and a diu­ret­ic by acti­vat­ing ­cyclic GMP for­ma­tion. We stud­ied the hemo­dy­nam­ic ­effects of con­tin­u­ous intra­ve­nous infu­sion of α-hANP on ­patients under­go­ing ­open-­heart sur­gery.
Methods. A total­ of 15 ­patients, includ­ing 7 ­with ­CABG, 4 ­with AVR, 2 ­with ­CABG ­plus AVR, and 2 ­with AVR ­plus MVR ­were ­involved in the ­study. They under­went ­open-­heart sur­gery in our insti­tute ­between July 1996 and April 1997. The ­mean age of ­patients was 68 ­years, rang­ing ­from 63 to 77. A dos­age of 0.05 µg/kg/min of α-hANP was admin­is­tered to all ­patients on post­op­er­a­tive day 1. Hemodynamics and ­blood and ­urine sam­ples ­were meas­ured at the fol­low­ing ­times: 2 ­hours ­before con­tin­u­ous intra­ve­nous infu­sion of α-hANP, 0, 1, 2, 3, 6, 12 and 24 ­hours ­after con­tin­u­ous intra­ve­nous infu­sion. We con­com­i­tant­ly meas­ured ­urine vol­ume and the plas­ma con­cen­tra­tion of α-hANP.
Results. The plas­ma con­cen­tra­tion of α-hANP ­increased suf­fi­cient­ly ­after the begin­ning of con­tin­u­ous intra­ve­nous infu­sion with­out any ­side ­effects, and the ­urine vol­ume ­increased too. The admin­is­tra­tion of α-hANP ­induced a ­decrease in cen­tral ­venous pres­sure, pul­mo­nary cap­il­lary ­wedged pres­sure and the pul­mo­nary vas­cu­lar resis­tance ­index. Systemic vas­cu­lar resis­tance ­index and car­diac out­put ­remained ­unchanged.
Conclusions. It is use­ful for the man­age­ment of ­patients ­with asso­ciat­ed vol­ume over­load fol­low­ing ­open-­heart sur­gery ­because the admin­is­tra­tion of α-hANP decreas­es pre­load and facil­i­tates sat­is­fac­to­ry uri­na­tion.

inizio pagina